Prognostic nomogram for sunitinib in pat
β
Robert J. Motzer; Ronald M. Bukowski; Robert A. Figlin; Thomas E. Hutson; M. Dro
π
Article
π
2008
π
John Wiley and Sons
π
English
β 115 KB
π 3 views
## Abstract ## BACKGROUND. In a randomized, phase 3 trial, sunitinib demonstrated superior efficacy over interferonβalfa as firstβline therapy in patients with metastatic clearβcell renal cell carcinoma (RCC). On the basis of outcome data from that trial, the authors developed a nomogram for predi